Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11650)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2020 (publication date) through Jun 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun XL, Chen SY, Tao SS, Qiao LC, Chen HJ, Yang BL. Optimized timing of using infliximab in perianal fistulizing Crohn's disease. World J Gastroenterol 2020; 26(14): 1554-1563 [PMID: 32327905 DOI: 10.3748/wjg.v26.i14.1554] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i14/1554.htm |
| Number | Citing Articles |
| 1 |
Brindusa Truta. Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place. World Journal of Gastroenterology 2022; 28(13): 1380-1383 doi: 10.3748/wjg.v28.i13.1380
|
| 2 |
Junya Song, Huihui Zhang, Huihua Zhang, Ximing Xu, Xiaohua Liang, Yongfang Liu, Xiaomei Song, Hong Guo, Xue Zhan, Jinlin Song, Xiaoqin Zhou. The role of proactive therapeutic drug monitoring in guiding infliximab therapeutic optimization in pediatric patients with Crohn's disease: A retrospective study. Pediatric Discovery 2024; 2(4) doi: 10.1002/pdi3.96
|
| 3 |
Francisco Rodríguez-Moranta, Federico Argüelles-Arias, Joaquín Hinojosa del Val, Marisa Iborra Colomino, M. Dolores Martín-Arranz, Luis Menchén Viso, Fernando Muñoz Núñez, Elena Ricart Gómez, José Germán Sánchez-Hernández, Teresa Valdés-Delgado, Jordi Guardiola Capón, Manuel Barreiro-de Acosta, Míriam Mañosa Ciria, Yamile Zabana Abdo, Ana Gutiérrez Casbas. Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU). Gastroenterología y Hepatología 2024; 47(5): 522 doi: 10.1016/j.gastrohep.2024.01.007
|
| 4 |
Aditi Kumar, Philip J Smith. Horizon scanning: new and future therapies in the management of inflammatory bowel disease. eGastroenterology 2023; 1(2): e100012 doi: 10.1136/egastro-2023-100012
|
| 5 |
Ye Ma, Runfeng Zhang, Wei Liu, Yinghao Sun, Jingnan Li, Hong Yang, Hong Lv, Yue Li, Bei Tan, Xiyu Sun, Jiaming Qian, Ji Li. Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02676-9
|
| 6 |
Jeroen Geldof, Nusrat Iqbal, Janindra Warusavitarne, Ailsa Hart. The Essential Role of a Multidisciplinary Approach in Inflammatory Bowel Diseases: Combined Medical-Surgical Treatment in Complex Perianal Fistulas in CD. Clinics in Colon and Rectal Surgery 2022; 35(01): 021 doi: 10.1055/s-0041-1740035
|
| 7 |
Xingtao Jin, Ye Han, Min Yang, Qianqian Ye, Qingming Wang, De Zheng, Zubing Mei. Global trends in surgically based treatment of anal fistula in Crohn’s disease: a bibliometric and visualization analysis. International Journal of Surgery 2025; 111(3): 2578 doi: 10.1097/JS9.0000000000002238
|
| 8 |
Feihong Deng, Pianpian Xia, Zengrong Wu, Hejun Zhou, Xuehong Wang. Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn’s Disease. International Journal of General Medicine 2021; : 3387 doi: 10.2147/IJGM.S315505
|
| 9 |
Jingjing Liu, Hongye Tang, Tingting Lin, Jiangchuan Wang, Wenjing Cui, Chao Xie, Zhongqiu Wang, Yugen Chen, Xiao Chen. Sarcopenia assessed by computed tomography or magnetic resonance imaging is associated with the loss of response to biologic therapies in adult patients with Crohn's disease. Clinical and Translational Science 2023; 16(11): 2209 doi: 10.1111/cts.13621
|
| 10 |
Francisco Rodríguez-Moranta, Federico Argüelles-Arias, Joaquín Hinojosa del Val, Marisa Iborra Colomino, M. Dolores Martín-Arranz, Luis Menchén Viso, Fernando Muñoz Núñez, Elena Ricart Gómez, José Germán Sánchez-Hernández, Teresa Valdés-Delgado, Jordi Guardiola Capón, Manuel Barreiro-de Acosta, Míriam Mañosa Ciria, Yamile Zabana Abdo, Ana Gutiérrez Casbas. Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis. Gastroenterología y Hepatología (English Edition) 2024; 47(5): 522 doi: 10.1016/j.gastre.2024.04.031
|